# Tolerability and Pharmacokinetics of Metformin and Metformin Extended Release (ER)

> **NCT00941239** · PHASE1 · COMPLETED · sponsor: **Laboratorios Silanes S.A. de C.V.** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** metformin ER
- **DRUG:** metformin

## Key facts

- **NCT ID:** NCT00941239
- **Lead sponsor:** Laboratorios Silanes S.A. de C.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2007-02
- **Final completion:** 2007-02
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2018-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00941239

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00941239, "Tolerability and Pharmacokinetics of Metformin and Metformin Extended Release (ER)". Retrieved via MORVS 2026-09-29 from https://api.morvs.ai/clinical/NCT00941239. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*